ClinicalTrials.gg
Sign In

Hip Dislocation clinical trials

The registry lists 107 studies for Hip Dislocation across more than 10 countries. 36 are recruiting or about to start. 60 of them are mainly about Hip Dislocation (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 2 narrower conditions too, such as Developmental Dysplasia of the Hip: 208 studies, 52 open.

Get an email when these change. Save the Hip Dislocation studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
34
Recruiting
24
Status unknown
17
Active, not recruiting
13
Not yet recruiting
9
Withdrawn
4

Phase

Phase 4
11
Phase 3
3
Phase 2
3

Where

United States
23
Denmark
17
Canada
9
Korea, Republic of
6
Poland
4
Netherlands
4

Who runs them

University of Aarhus (6) · Zimmer Biomet (5) · University of British Columbia (4) · University of Southern Denmark (4) · Poznan University of Medical Sciences (4) · EUROS (3) · Ottawa Hospital Research Institute (3) · Mayo Clinic (3)

What is being tested here

Drugs under test in Hip Dislocation studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ropivacaine306
Dexamethasone012
Saline Solution011
Sodium Chloride011
Clonidine001
Epinephrine001
Fentanyl001
Propofol001
Rocuronium001
Sevoflurane001

Coming up

0phase 3 studies under way
11studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 24 Hip Dislocation studies recruiting now, 6 (25%) set no upper age limit and 17 (71%) stop at 75 or younger. 16 (67%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 5 (21%) take healthy volunteers.

Recruiting studies that take each age, of 24
AgeWomenMen
109 (38%)9 (38%)
1815 (63%)15 (63%)
3012 (50%)12 (50%)
4011 (46%)11 (46%)
5011 (46%)11 (46%)
658 (33%)8 (33%)
758 (33%)8 (33%)
857 (29%)7 (29%)

Across all 107 studies, recruiting or not: 55% stop at 75 or younger and 52% at 65; 52% take children; 0% are for women only and 0% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hip Dislocation studies take

Of 32 interventional studies with no phase under Hip Dislocation, half reached primary completion within 45 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase45 mo18–… · 32 studies——
Observational83 mo41–113 · 20 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 107. Browse all 107 → or search them.